LEADER 01191nam--2200373---450 001 990003655360203316 005 20190208094831.0 010 $a9789812832733 035 $a000365536 035 $aUSA01000365536 035 $a(ALEPH)000365536USA01 035 $a000365536 100 $a20120426d2008----km-y0itay50------ba 101 $aeng 102 $aUS 105 $a||||||||001yy 200 1 $a<> elementary introduction to stochastic interest rate modeling$fNicolas Privault 210 $aHackensack, NJ$cWorld Scientific$d2008 215 $axi, 178 p.$cill.$d24 cm. 225 2 $aAdvanced series on statistical science & applied probability$v12 410 0$12001$aAdvanced series on statistical science & applied probability$v12 454 1$12001 461 1$1001-------$12001 606 0 $aModelli stocastici 676 $a332.63 700 1$aPRIVAULT,$bNicolas$0475313 801 0$aIT$bsalbc$gISBD 912 $a990003655360203316 951 $a300 332.63 PRI$b309 DISES 959 $aBK 969 $aDISES 979 $aMORRIELLO$b10$c20120426$lUSA01$h1537 996 $aElementary introduction to stochastic interest rate modeling$91139892 997 $aUNISA LEADER 01298nam a2200301 i 4500 001 991002577769707536 008 140806s2011 it 001 0 ita d 020 $a9788890557705 035 $ab14197546-39ule_inst 040 $aDip. Studi Giuridici$bita 082 04$a634.92 082 04$a574.52642 245 00$aPianificazione ecologica dei sistemi forestali /$cPiermaria Corona, Anna Barbati, Barbara Ferrara ... [et al.] 260 $aArezzo : Compagnia delle Foreste, 2011 300 $a205 p. ;$bill.$c27 cm 440 0$aScienze forestali e ambientali 650 4$aBoschi e foreste$xPianificazione 650 4$aBoschi e foreste$xEcologia 650 4$aEcologia forestale 700 $aCorona, Piermaria$eauthor$4http://id.loc.gov/vocabulary/relators/aut 700 1 $aBarbati, Anna$eauthor$4http://id.loc.gov/vocabulary/relators/aut 700 1 $aFerrara, Barbara$eauthor$4http://id.loc.gov/vocabulary/relators/aut 907 $a.b14197546$b07-08-14$c06-08-14 912 $a991002577769707536 945 $aLE027 PROG. 5x1000 M 142$g1$i2027000328505$lle027$nProgetto 5 per 1000$op$pE35.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i15629594$z07-08-14 996 $aPianificazione ecologica dei sistemi forestali$9257876 997 $aUNISALENTO 998 $ale027$b06-08-14$cm$da $e-$fita$git $h0$i0 LEADER 05667nam 2201525z- 450 001 9910557641503321 005 20210501 035 $a(CKB)5400000000045038 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69333 035 $a(oapen)doab69333 035 $a(EXLCZ)995400000000045038 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBacteriophages$eAlternatives to Antibiotics and Beyond 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (390 p.) 311 08$a3-03943-404-7 311 08$a3-03943-405-5 330 $aThere is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous "O'Neill Report" (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a "one health" approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around "forever" can come to our rescue-bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need-human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation. 517 $aBacteriophages 606 $aMedicine and Nursing$2bicssc 610 $aAeromonas hydrophila 610 $aAeromonas salmonicida 610 $aagent based 610 $aAmerican Foulbrood 610 $aantibacterial 610 $aantibiotic 610 $aantibiotic resistance 610 $aAntibiotic-resistant bacteria 610 $aantibiotics 610 $aantimicrobial 610 $aantimicrobial agent 610 $aantimicrobial resistance 610 $aantimicrobials 610 $aaquaculture 610 $abacterial phage resistance 610 $abacteriophage 610 $abacteriophage therapy 610 $abacteriophages 610 $aBacteriophages 610 $abiofilm 610 $abiofilms 610 $abiological control 610 $aBrevibacillus laterosporus 610 $abystander phage therapy 610 $aCBD-independent 610 $achallenge trials 610 $aClostridium difficile 610 $aClostridium difficile infection 610 $aCRISPR CAS 610 $adairy industry 610 $adiabetic foot ulcer 610 $adirected evolution 610 $adual-species 610 $aendolysin 610 $aenzybiotics 610 $aevolution 610 $afermentation failure 610 $afish larvae 610 $aFoldX 610 $afurunculosis 610 $ahorizontal gene transfer, transduction 610 $ain vitro fermentation model 610 $ainfrared spectroscopy 610 $ainteractions 610 $aKayvirus 610 $alactic acid bacteria 610 $alysin 610 $alysins 610 $alysogenic conversion 610 $alytic enzyme 610 $amarine vibrios 610 $aMAS 610 $amass action 610 $amicrobiome 610 $amicrobiome therapy 610 $amodels 610 $aMotile Aeromonas Septicemia 610 $aMRSA 610 $amultiple-antibiotic-resistance 610 $amycobacteriophages 610 $aMycobacterium smegmatis 610 $aNagoya Protocol 610 $aone health 610 $aosteomyelitis 610 $aPaenibacillus larvae 610 $apathogens 610 $apeptidoglycan hydrolase 610 $aphage 610 $aphage display 610 $aphage isolation 610 $aphage resistance 610 $aphage therapy 610 $aphage-resistant mutants 610 $aPlyC CHAP 610 $aprophage induction 610 $aprotein engineering 610 $aprotein net charge 610 $aproteins 610 $aPseudomonas aeruginosa 610 $aread recruitment 610 $aregression modeling 610 $aresistance 610 $asafety 610 $asequential 610 $ashiga toxin 610 $asimultaneous 610 $aStaphylococcus 610 $aStaphylococcus aureus 610 $aSTEC O145 strains 610 $aSTEC-specific bacteriophage 610 $astriped catfish (Pangasianodon hypophthalmus) 610 $asynergy 610 $atreatment 610 $aVibrio anguillarum 610 $avibriosis 610 $awhole genome sequencing 615 7$aMedicine and Nursing 700 $aSuárez$b Pilar García$4edt$01305903 702 $aFernández$b Lucía$4edt 702 $aSuárez$b Pilar García$4oth 702 $aFernández$b Lucía$4oth 906 $aBOOK 912 $a9910557641503321 996 $aBacteriophages$93027995 997 $aUNINA